Literature DB >> 1776759

Abnormalities of glucose metabolism in Alzheimer's disease.

S Hoyer1.   

Abstract

In normoglycemic patients with either incipient early-onset or incipient late-onset dementia of the Alzheimer type, the predominant disturbance consisted of a significant reduction in cerebral glucose utilization. Alterations in cerebral blood flow and oxygen consumption first occurred in late-onset dementia types. In advanced late-onset dementia, these parameters had decreased most severely. The calculated ATP production rate from glucose indicated a drastic loss of energy in all patients studied. As not all oxygen consumed by the brain was used for glucose oxidation, oxidation of substrates other than glucose (endogenous amino acids and free fatty acids) is assumed to minimize the energy loss from glucose. The possibility that the abnormalities in oxidative and energy metabolism in dementias of the Alzheimer's type are due to metabolic abnormalities in glycolytic glucose breakdown and pyruvate oxidation, rather than to an uncoupling of oxidative phosphorylation, is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776759     DOI: 10.1111/j.1749-6632.1991.tb00190.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  29 in total

1.  Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence.

Authors:  Jia Yao; Ryan T Hamilton; Enrique Cadenas; Roberta Diaz Brinton
Journal:  Biochim Biophys Acta       Date:  2010-06-09

2.  Amyloid precursor protein in pancreatic islets.

Authors:  Joshua A Kulas; Kendra L Puig; Colin K Combs
Journal:  J Endocrinol       Date:  2017-07-14       Impact factor: 4.286

3.  Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.

Authors:  Jia Yao; Ronald W Irwin; Liqin Zhao; Jon Nilsen; Ryan T Hamilton; Roberta Diaz Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

4.  Simultaneous voltammetric detection of glucose and lactate fluctuations in rat striatum evoked by electrical stimulation of the midbrain.

Authors:  Alexandra G Forderhase; Hannah C Styers; Christie A Lee; Leslie A Sombers
Journal:  Anal Bioanal Chem       Date:  2020-07-14       Impact factor: 4.142

Review 5.  Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle.

Authors:  A Popa-Wagner; Ana-Maria Buga; B Popescu; D Muresanu
Journal:  J Neural Transm (Vienna)       Date:  2013-12-14       Impact factor: 3.575

6.  Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Katalin Völgyi; Kata Badics; Fernando J Sialana; Péter Gulyássy; Edina Brigitta Udvari; Viktor Kis; László Drahos; Gert Lubec; Katalin Adrienna Kékesi; Gábor Juhász
Journal:  Mol Neurobiol       Date:  2018-02-22       Impact factor: 5.590

7.  Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues.

Authors:  Joshua A Kulas; Whitney F Franklin; Nicholas A Smith; Gunjan D Manocha; Kendra L Puig; Kumi Nagamoto-Combs; Rachel D Hendrix; Giulio Taglialatela; Steven W Barger; Colin K Combs
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-11-13       Impact factor: 4.310

Review 8.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

9.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

10.  Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.

Authors:  M L Bush; J S Miyashiro; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.